Cryo Cell International (CCEL) Assets Average (2011 - 2026)

Cryo Cell International (CCEL) has reported Assets Average for 16 consecutive years, with $60.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Assets Average fell 5.61% year-over-year to $60.8 million; the TTM figure through May 2026 stood at $60.8 million (down 5.61% YoY), while the FY2025 annual figure was $63.2 million, down 2.28% from the prior year.
• Assets Average slipped to $60.8 million in Q2 2026 per CCEL's latest filing, from $61.3 million in the prior quarter.
• Across five years, Assets Average topped out at $69.3 million in Q3 2023 and bottomed at $55.1 million in Q2 2022.
• Historically, Assets Average has averaged $63.2 million across 5 years, with a median of $63.5 million in 2024.
• Annual changes were most pronounced in 2022 — Assets Average retreated 29.1% — and 2023, when it rose 22.4%.
• Cryo Cell International's Assets Average stood at $65.8 million in 2022, then climbed by 2.14% to $67.2 million in 2023, then decreased by 5.1% to $63.8 million in 2024, then decreased by 2.13% to $62.4 million in 2025, then decreased by 2.65% to $60.8 million in 2026.
• Business Quant data shows CCEL's Assets Average at $60.8 million in Q2 2026, $61.3 million in Q1 2026, and $62.4 million in Q4 2025.